Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Endexx Corporation (EDXC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0310-0.0020 (-6.06%)
At close: 03:05PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0330
Open0.0330
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0310 - 0.0330
52 Week Range0.0002 - 0.1550
Volume187,391
Avg. Volume339,908
Market Cap15.513M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0180
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for EDXC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ENDEXX CORPORATION
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
  • GlobeNewswire

    Endexx Announces Fiscal Second Quarter 2022

    Endexx Q2 Year over Year quarterly sales increase 73% CAVE CREEK, AZ, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTC: EDXC), a provider of innovative Hemp-derived wellness and nutritional products, today announced its Form 10Q, Second quarter ending March 31, 2022. Endexx continues to rebound and show growth in mass retail sales. The pandemic significantly impacted Endexx’s wholesale clients as many were forced to close their doors. The added 2800 new mass retail sto

  • GlobeNewswire

    Endexx Announces Fiscal First Quarter 2022 Endexx Q1 Year over Year Sales Increase 85%

    CAVE CREEK, AZ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a provider of innovative Hemp-derived wellness and nutritional products, today announced its Form 10Q, first quarter ending December 31, 2021. Endexx continues to rebound and grow following two years of pandemic and economic challenges. Ongoing supply chain issues impacted packaging and individual ingredient availability and may continue to delay some production runs in key product sets during

  • GlobeNewswire

    EDXC Releases Audited 10K Financial Report

    Endexx Reduces Liabilities While Rebooting Sales Momentum CAVE CREEK, AZ, April 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx, Inc. (OTC: EDXC) today released a special letter to shareholders addressing the 10K and recent major events in the hemp industry. The shareholder updates from CEO Todd Davis are included in their entirety below. Dear Shareholders: The “Covid Pandemic”, politics, and the conflict in Ukraine consume the headlines daily. Endexx remains driven and on track to achiev

Advertisement
Advertisement